Furthermore, EIF4E expression is significantly correlated with both recurrence and relapse-free survival in HNSCC patients, with the PI3K/AKT/mTOR signaling pathway being highly activated (59). The gene discussed is EIF4E; the disease is head and neck squamous cell carcinoma.